{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:46:10Z","timestamp":1788871570081,"version":"build-2803163510"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"crossref"}]},{"name":"MECSST"},{"DOI":"10.13039\/501100003478","name":"MHLW","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Global COE Program"},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.07.016","type":"journal-article","created":{"date-parts":[[2012,7,15]],"date-time":"2012-07-15T05:50:13Z","timestamp":1342331413000},"page":"348-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine"],"prefix":"10.1016","volume":"64","author":[{"given":"Osamu","family":"Uchiumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Scott","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Sora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.07.016_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02244861","article-title":"Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats","volume":"114","author":"Acri","year":"1994","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/oxfordjournals.schbul.a033320","article-title":"Schizophrenia, sensory gating, and nicotinic receptors","volume":"24","author":"Adler","year":"1998","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1471-4159.2002.01128.x","article-title":"Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in\u00a0vivo in the frontal cortex of mice","volume":"83","author":"Ago","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib5","unstructured":"Arime, Y., Kasahara, Y., Hall, F.S., Uhl, G.R., Sora, I. Cortico-subcortical neuromodulation involved in the amelioration of prepulse inhibition deficits in dopamine transporter knockout mice. Neuropsychopharmacology, in press."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1248\/bpb.34.1373","article-title":"Animal models of attention-deficit\/hyperactivity disorder","volume":"34","author":"Arime","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib7","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/S0028-3908(00)00099-X","article-title":"Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory","volume":"39","author":"Bancroft","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib8","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1073\/pnas.0401418101","article-title":"Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine","volume":"101","author":"Budygin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0197-0186(96)00124-6","article-title":"[3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia","volume":"30","author":"Burnet","year":"1997","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"RC141","key":"10.1016\/j.neuropharm.2012.07.016_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1523\/JNEUROSCI.21-09-j0001.2001","article-title":"Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene","volume":"21","author":"Carboni","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1054-3589(08)57010-4","article-title":"Preclinical behavioral models for predicting antipsychotic activity","volume":"57","author":"Castagne","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/1064-1297.16.3.207","article-title":"Proximal versus distal cues to smoke: the effects of environments on smokers' cue-reactivity","volume":"16","author":"Conklin","year":"2008","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1176\/ajp.155.11.1490","article-title":"Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings","volume":"155","author":"Dalack","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002130050328","article-title":"Serotonin1B receptor modulation of startle reactivity, habituation, and prepulse inhibition in wild-type and serotonin1B knockout mice","volume":"132","author":"Dulawa","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/mehy.1997.0623","article-title":"Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research","volume":"52","author":"Dursun","year":"1999","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0006-3223(99)00122-5","article-title":"Functional hyperdopaminergia in dopamine transporter knock-out mice","volume":"46","author":"Gainetdinov","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1126\/science.283.5400.397","article-title":"Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity","volume":"283","author":"Gainetdinov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/syn.20526","article-title":"Serotoninergic dorsal raphe neurons possess functional postsynaptic nicotinic acetylcholine receptors","volume":"62","author":"Galindo-Charles","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.schres.2006.05.022","article-title":"A\u00a0preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms","volume":"87","author":"George","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0817s24","article-title":"Assessment of murine startle reactivity, prepulse inhibition, and habituation","author":"Geyer","year":"2003","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib22","article-title":"Measurement of startle response, prepulse inhibition, and habituation","author":"Geyer","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainres.2006.01.056","article-title":"The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing","volume":"1078","author":"Giakoumaki","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib24","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/379606a0","article-title":"Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter","volume":"379","author":"Giros","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neulet.2004.11.073","article-title":"Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL\/6 mice","volume":"377","author":"Gould","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/schbul\/sbn156","article-title":"Perception measurement in clinical trials of schizophrenia: promising paradigms from CNTRICS","volume":"35","author":"Green","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0306-4522(02)00379-2","article-title":"Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions","volume":"115","author":"Hall","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1749-6632.2011.06415.x","article-title":"Mouse models for studying genetic influences on factors determining smoking cessation success in humans","volume":"1248","author":"Hall","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neubiorev.2005.02.006","article-title":"Nicotine use in schizophrenia: the self medication hypotheses","volume":"29","author":"Kumari","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/schbul\/22.3.431","article-title":"Nicotinic receptor function in schizophrenia","volume":"22","author":"Leonard","year":"1996","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0306-4522(01)00538-3","article-title":"Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory","volume":"109","author":"Levin","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02805971","article-title":"Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs","volume":"127","author":"Levin","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejphar.2009.11.036","article-title":"Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice","volume":"628","author":"Li","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0188-4409(99)00087-9","article-title":"Nicotine, brain nicotinic receptors, and neuropsychiatric disorders","volume":"31","author":"Mihailescu","year":"2000","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(02)02244-6","article-title":"Mechanisms of nicotine actions on dorsal raphe serotoninergic neurons","volume":"452","author":"Mihailescu","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0091-3057(96)00465-0","article-title":"Cocaine reward and locomotor activity in C57BL\/6J and 129\/SvJ inbred mice and their F1 cross","volume":"58","author":"Miner","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00213-009-1651-z","article-title":"Therapeutic potential of nicotine for methamphetamine-induced impairment of sensorimotor gating: involvement of pallidotegmental neurons","volume":"207","author":"Mizoguchi","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib38","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/sj.npp.1301354","article-title":"Parallel loss of hippocampal LTD and cognitive flexibility in a genetic model of hyperdopaminergia","volume":"32","author":"Morice","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002","article-title":"Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines","volume":"22","author":"Moron","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib40","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.schres.2007.03.033","article-title":"A\u00a0single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia","volume":"94","author":"Mu","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0166-4328(02)00042-6","article-title":"The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase","volume":"134","author":"Muller","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib42","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/npp.2010.12","article-title":"Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers","volume":"35","author":"Petrovsky","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0893-133X(99)00146-3","article-title":"Nicotinic receptors in the brain. Links between molecular biology and behavior","volume":"22","author":"Picciotto","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bbr.2006.09.015","article-title":"Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit\/hyperactivity disorder?","volume":"175","author":"Potter","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib46","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/FBP.0b013e32830dc110","article-title":"Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice","volume":"19","author":"Powell","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib47","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2009.04.021","article-title":"Prepulse inhibition and genetic mouse models of schizophrenia","volume":"204","author":"Powell","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1523\/JNEUROSCI.21-01-00305.2001","article-title":"Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists","volume":"21","author":"Ralph","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1185\/030079904125004060","article-title":"Nicotinic receptors and schizophrenia","volume":"20","author":"Ripoll","year":"2004","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib51","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainresbull.2005.02.032","article-title":"Lower core body temperature and attenuated nicotine-induced hypothermic response in mice lacking the beta4 neuronal nicotinic acetylcholine receptor subunit","volume":"66","author":"Sack","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib53","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-003-1515-x","article-title":"The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice","volume":"170","author":"Sakaue","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib54","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjp.0703139","article-title":"Postsynaptic 5-hydroxytryptamine(1A) receptor activation increases in\u00a0vivo dopamine release in rat prefrontal cortex","volume":"129","author":"Sakaue","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bcp.2009.04.019","article-title":"nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms","volume":"78","author":"Sarter","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib56","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-001-0927-8","article-title":"Effects of alpha 4\/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice","volume":"159","author":"Schreiber","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2008.09.026","article-title":"Chronic reductions in serotonin transporter function prevent 5-HT1B-induced behavioral effects in mice","volume":"65","author":"Shanahan","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib58","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.brainresbull.2008.03.017","article-title":"Nicotine-induced monoamine neurotransmitter changes in the brain of young rats","volume":"76","author":"Shearman","year":"2008","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib59","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/sj.npp.1300476","article-title":"Regional differences in extracellular dopamine and serotonin assessed by in\u00a0vivo microdialysis in mice lacking dopamine and\/or serotonin transporters","volume":"29","author":"Shen","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib60","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1073\/pnas.091039298","article-title":"Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference","volume":"98","author":"Sora","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib61","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1073\/pnas.95.13.7699","article-title":"Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice","volume":"95","author":"Sora","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib62","unstructured":"Soria-Fregozo, C.F.-S., P\u00e9rez-Vega, M.E., Feria-Velasco, M.I., Feria-Velasco, A. 5-HT denervation of the adult rat prefrontal cortex induces changes in the expression of \u03b14 and \u03b17 nicotinic acetylcholine receptor subtypes. Neurologia, in press."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib63","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130100901","article-title":"Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter","volume":"159","author":"Spielewoy","year":"2001","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib64","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.schres.2007.06.008","article-title":"Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Sumiyoshi","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib65","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/archpsyc.63.12.1325","article-title":"Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function","volume":"63","author":"Swerdlow","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib66","first-page":"611","article-title":"Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein","volume":"58","author":"Wedzony","year":"2007","journal-title":"J.\u00a0Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib67","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.neuropharm.2007.02.002","article-title":"Functional alterations of nicotinic neurotransmission in dopamine transporter knock-out mice","volume":"52","author":"Weiss","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib68","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.bcp.2007.07.002","article-title":"Neuronal nicotinic receptor agonists for the treatment of attention-deficit\/hyperactivity disorder: focus on cognition","volume":"74","author":"Wilens","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.016_bib69","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/sj.npp.1301009","article-title":"Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice","volume":"31","author":"Yamashita","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.016_bib70","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:43:07Z","timestamp":1758436987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":70,"alternative-id":["S0028390812003528"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.016","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}